Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
2012 was not the best year for jobs, although it did get better as the year went on, going from an 8.3% unemployment rate in the U.S. in January to 7.8% in December. However, while layoffs might be happening less and less often, they’re still occurring in every industry, including biopharma. You’ve seen our list of the top 10 biopharma layoffs of 2012; were YOU one of the casualties?